Literature DB >> 28197379

Caspase-2 and oxidative stress underlie the immunogenic potential of high hydrostatic pressure-induced cancer cell death.

Irena Moserova1, Iva Truxova1, Abhishek D Garg2, Jakub Tomala3, Patrizia Agostinis2, Pierre Francois Cartron4, Sarka Vosahlikova5, Marek Kovar3, Radek Spisek1, Jitka Fucikova1.   

Abstract

High hydrostatic pressure (HHP) promotes key characteristics of immunogenic cell death (ICD), in thus far resembling immunogenic chemotherapy and ionizing irradiation. Here, we demonstrate that cancer cells succumbing to HHP induce CD4+ and CD8+ T cell-dependent protective immunity in vivo. Moreover, we show that cell death induction by HHP relies on the overproduction of reactive oxygen species (ROS), causing rapid establishment of the integrated stress response, eIF2α phosphorylation by PERK, and sequential caspase-2, -8 and -3 activation. Non-phosphorylatable eIF2α, depletion of PERK, caspase-2 or -8 compromised calreticulin exposure by cancer cells succumbing to HHP but could not inhibit death. Interestingly, the phagocytosis of HHP-treated malignant cells by dendritic cells was suppressed by the knockdown of caspase-2 in the former. Thus, caspase-2 mediates a key function in the interaction between dying cancer cells and antigen presenting cells. Our results indicate that the ROSPERK→eIF2α→caspase-2 signaling pathway is central for the perception of HHP-driven cell death as immunogenic.

Entities:  

Keywords:  Caspases; ER stress; ecto-CALR; high hydrostatic pressure; immunogenic cell death

Year:  2016        PMID: 28197379      PMCID: PMC5283635          DOI: 10.1080/2162402X.2016.1258505

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  35 in total

Review 1.  The PERKs of damage-associated molecular patterns mediating cancer immunogenicity: From sensor to the plasma membrane and beyond.

Authors:  A R van Vliet; S Martin; A D Garg; P Agostinis
Journal:  Semin Cancer Biol       Date:  2015-04-13       Impact factor: 15.707

2.  Immunogenic death of colon cancer cells treated with oxaliplatin.

Authors:  A Tesniere; F Schlemmer; V Boige; O Kepp; I Martins; F Ghiringhelli; L Aymeric; M Michaud; L Apetoh; L Barault; J Mendiboure; J-P Pignon; V Jooste; P van Endert; M Ducreux; L Zitvogel; F Piard; G Kroemer
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

3.  Calreticulin exposure dictates the immunogenicity of cancer cell death.

Authors:  Michel Obeid; Antoine Tesniere; François Ghiringhelli; Gian Maria Fimia; Lionel Apetoh; Jean-Luc Perfettini; Maria Castedo; Grégoire Mignot; Theoharis Panaretakis; Noelia Casares; Didier Métivier; Nathanael Larochette; Peter van Endert; Fabiola Ciccosanti; Mauro Piacentini; Laurence Zitvogel; Guido Kroemer
Journal:  Nat Med       Date:  2006-12-24       Impact factor: 53.440

4.  Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma.

Authors:  Shohei Miyamoto; Hiroyuki Inoue; Takafumi Nakamura; Meiko Yamada; Chika Sakamoto; Yasuo Urata; Toshihiko Okazaki; Tomotoshi Marumoto; Atsushi Takahashi; Koichi Takayama; Yoichi Nakanishi; Hiroyuki Shimizu; Kenzaburo Tani
Journal:  Cancer Res       Date:  2012-03-29       Impact factor: 12.701

Review 5.  Surface-exposed calreticulin in the interaction between dying cells and phagocytes.

Authors:  Isabelle Martins; Oliver Kepp; Lorenzo Galluzzi; Laura Senovilla; Frederic Schlemmer; Sandy Adjemian; Laurie Menger; Mickael Michaud; Laurence Zitvogel; Guido Kroemer
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

6.  ROS-triggered caspase 2 activation and feedback amplification loop in beta-carotene-induced apoptosis.

Authors:  Vandna Prasad; Anmol Chandele; Jayashree C Jagtap; P Sudheer Kumar; Padma Shastry
Journal:  Free Radic Biol Med       Date:  2006-04-18       Impact factor: 7.376

7.  Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation.

Authors:  Nathalie E Blachère; Robert B Darnell; Matthew L Albert
Journal:  PLoS Biol       Date:  2005-04-26       Impact factor: 8.029

8.  Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer.

Authors:  Michal Podrazil; Rudolf Horvath; Etienne Becht; Daniela Rozkova; Pavla Bilkova; Klara Sochorova; Hana Hromadkova; Jana Kayserova; Katerina Vavrova; Jan Lastovicka; Petra Vrabcova; Katerina Kubackova; Zdenka Gasova; Ladislav Jarolim; Marek Babjuk; Radek Spisek; Jirina Bartunkova; Jitka Fucikova
Journal:  Oncotarget       Date:  2015-07-20

9.  Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death.

Authors:  Abhishek D Garg; Lorenzo Galluzzi; Lionel Apetoh; Thais Baert; Raymond B Birge; José Manuel Bravo-San Pedro; Karine Breckpot; David Brough; Ricardo Chaurio; Mara Cirone; An Coosemans; Pierre G Coulie; Dirk De Ruysscher; Luciana Dini; Peter de Witte; Aleksandra M Dudek-Peric; Alberto Faggioni; Jitka Fucikova; Udo S Gaipl; Jakub Golab; Marie-Lise Gougeon; Michael R Hamblin; Akseli Hemminki; Martin Herrmann; James W Hodge; Oliver Kepp; Guido Kroemer; Dmitri V Krysko; Walter G Land; Frank Madeo; Angelo A Manfredi; Stephen R Mattarollo; Christian Maueroder; Nicolò Merendino; Gabriele Multhoff; Thomas Pabst; Jean-Ehrland Ricci; Chiara Riganti; Erminia Romano; Nicole Rufo; Mark J Smyth; Jürgen Sonnemann; Radek Spisek; John Stagg; Erika Vacchelli; Peter Vandenabeele; Lien Vandenberk; Benoit J Van den Eynde; Stefaan Van Gool; Francesca Velotti; Laurence Zitvogel; Patrizia Agostinis
Journal:  Front Immunol       Date:  2015-11-20       Impact factor: 7.561

10.  Endoplasmic reticulum stress-mediated activation of p38 MAPK, Caspase-2 and Caspase-8 leads to abrin-induced apoptosis.

Authors:  Ritu Mishra; Anjali A Karande
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

View more
  11 in total

Review 1.  Unraveling the regulatory role of endoplasmic-reticulum-associated degradation in tumor immunity.

Authors:  Xiaodan Qin; William D Denton; Leah N Huiting; Kaylee S Smith; Hui Feng
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-07-07       Impact factor: 8.250

Review 2.  Trial watch: dendritic cell vaccination for cancer immunotherapy.

Authors:  Jenny Sprooten; Jolien Ceusters; An Coosemans; Patrizia Agostinis; Steven De Vleeschouwer; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi; Abhishek D Garg
Journal:  Oncoimmunology       Date:  2019-07-18       Impact factor: 8.110

3.  Downregulation of PERK activity and eIF2α serine 51 phosphorylation by mTOR complex 1 elicits pro-oxidant and pro-death effects in tuberous sclerosis-deficient cells.

Authors:  Jothilatha Krishnamoorthy; Clara Tenkerian; Jyotsana Gupta; Nour Ghaddar; Shuo Wang; Cedric Darini; Kirk A Staschke; Abhishek Ghosh; Valentina Gandin; Ivan Topisirovic; Arnold S Kristof; Maria Hatzoglou; George Simos; Antonis E Koromilas
Journal:  Cell Death Dis       Date:  2018-02-15       Impact factor: 8.469

Review 4.  Type I interferons and endoplasmic reticulum stress in health and disease.

Authors:  Jenny Sprooten; Abhishek D Garg
Journal:  Int Rev Cell Mol Biol       Date:  2019-11-19       Impact factor: 6.813

Review 5.  Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology.

Authors:  Isaure Vanmeerbeek; Jenny Sprooten; Dirk De Ruysscher; Sabine Tejpar; Peter Vandenberghe; Jitka Fucikova; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi; Abhishek D Garg
Journal:  Oncoimmunology       Date:  2020-01-09       Impact factor: 8.110

Review 6.  Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications.

Authors:  Jitka Fucikova; Lenka Palova-Jelinkova; Jirina Bartunkova; Radek Spisek
Journal:  Front Immunol       Date:  2019-10-29       Impact factor: 7.561

Review 7.  Nonthermal plasma as part of a novel strategy for vaccination.

Authors:  Hager Mohamed; Rita A Esposito; Michele A Kutzler; Brian Wigdahl; Fred C Krebs; Vandana Miller
Journal:  Plasma Process Polym       Date:  2020-07-13       Impact factor: 3.877

8.  Research and application of hydrostatic high pressure in tumor vaccines (Review).

Authors:  Shuai Yan; Kai Liu; Lin Mu; Jianfeng Liu; Wan Tang; Bin Liu
Journal:  Oncol Rep       Date:  2021-03-24       Impact factor: 3.906

9.  Hmox1 Upregulation Is a Mutual Marker in Human Tumor Cells Exposed to Physical Plasma-Derived Oxidants.

Authors:  Sander Bekeschus; Eric Freund; Kristian Wende; Rajesh Kumar Gandhirajan; Anke Schmidt
Journal:  Antioxidants (Basel)       Date:  2018-10-27

Review 10.  Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.

Authors:  Lorenzo Galluzzi; Ilio Vitale; Sarah Warren; Sandy Adjemian; Patrizia Agostinis; Aitziber Buqué Martinez; Timothy A Chan; George Coukos; Sandra Demaria; Eric Deutsch; Dobrin Draganov; Richard L Edelson; Silvia C Formenti; Jitka Fucikova; Lucia Gabriele; Udo S Gaipl; Sofia R Gameiro; Abhishek D Garg; Encouse Golden; Jian Han; Kevin J Harrington; Akseli Hemminki; James W Hodge; Dewan Md Sakib Hossain; Tim Illidge; Michael Karin; Howard L Kaufman; Oliver Kepp; Guido Kroemer; Juan Jose Lasarte; Sherene Loi; Michael T Lotze; Gwenola Manic; Taha Merghoub; Alan A Melcher; Karen L Mossman; Felipe Prosper; Øystein Rekdal; Maria Rescigno; Chiara Riganti; Antonella Sistigu; Mark J Smyth; Radek Spisek; John Stagg; Bryan E Strauss; Daolin Tang; Kazuki Tatsuno; Stefaan W van Gool; Peter Vandenabeele; Takahiro Yamazaki; Dmitriy Zamarin; Laurence Zitvogel; Alessandra Cesano; Francesco M Marincola
Journal:  J Immunother Cancer       Date:  2020-03       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.